Research and analysis

Antenatal and newborn screening KPI data: Q3 summary factsheets (1 October to 31 December 2023)

Updated 19 September 2024

Applies to England

© Crown copyright 2024

This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.

Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.

This publication is available at https://www.gov.uk/government/publications/q3-1-oct-to-31-dec-2023-annb-and-ypa-screening-kpi-data/antenatal-and-newborn-screening-kpi-data-q3-summary-factsheets-1-october-to-31-december-2023

This report should be read in conjunction with the full KPI data tables published each quarter.

1. Fetal anomaly screening

1.1 KPI FA2: coverage: fetal anomaly ultrasound

National performance of FA2 (see standard FASP-SO2) in quarter 2 2023 to 2024 was 98.7%. FA2 is collected 6 months (2 quarters) in arrears.

Quarter 2 performance

Reporting period Numerator Denominator Performance %
Quarter 2 2023 to 2024 130,485 132,169 98.7%
Region Performance %
East of England 99.1%
London 98.1%
Midlands 98.9%
North East and Yorkshire 99.1%
North West 98.7%
South East 98.7%
South West 98.8%
England 98.7%

1.2 KPI FA3

There is no intention to publish FA3 (see standard FASP-S01) by individual maternity service.

1.3 KPI FA4: combined samples

FA4 (see standard FASP-SO6) was introduced in 2020 to 2021. New KPIs are not published in the first year of data collection. This time is used to improve the data quality and completeness, by revising the definition, adding clarity and / or setting thresholds as required.

In quarter 3 2023 to 2024, national performance of FA4 for inadequate combined samples was 3.7%. FA4 is a KPI where a lower performance is better.

Quarter 3 performance

Reporting period Numerator Denominator Performance %
Quarter 3 2023 to 2024 4,059 108,412 3.7%
Region Performance %
East of England 2.4%
London 1.5%
Midlands 4.3%
North East and Yorkshire 6.5%
North West 4.1%
South East 4.5%
South West 3.4%
England 3.7%

1.4 KPI FA4: quadruple samples

FA4 (see standard FASP-SO6) was introduced in 2020 to 2021. New KPIs are not published in the first year of data collection. This time is used to improve the data quality and completeness, by revising the definition, adding clarity and / or setting thresholds as required.

In quarter 3 2023 to 2024, national performance of FA4 for inadequate quadruple samples was 7.9%. FA4 is a KPI where a lower performance is better.

Quarter 3 performance

Reporting period Numerator Denominator Performance %
Quarter 3 2023 to 2024 977 12,447 7.8%
Region Performance %
East of England 4.7%
London 3.2%
Midlands 7.9%
North East and Yorkshire 13.1%
North West 6.3%
South East 13.1%
South West 13.6%
England 7.9%

2. Infectious diseases in pregnancy screening

2.1 KPI ID1: HIV coverage

National performance of ID1 (see standard IDPS-S01) in quarter 3 2023 to 2024 was 99.8%.

Quarter 3 performance

Reporting period Numerator Denominator Performance %
Quarter 3 2023 to 2024 150,994 151,262 99.8%
Region Performance %
East of England 99.8%
London 99.9%
Midlands 99.8%
North East and Yorkshire 99.8%
North West 99.8%
South East 99.8%
South West 99.7%
England 99.8%

2.2 KPI ID2: diagnosis/intervention: timely assessment of women with hepatitis B

National performance of ID2 (see standard IDPS-S06) in quarter 3 2023 to 2024 was 68.6%. The submission of data for ID2 has changed in 2023 to 2024 from maternity service self-reporting to the Integrated Screening Outcomes Surveillance Service (ISOSS) to improve consistency and accuracy of data returns. This has led to an expected reduction in performance as a result of more accurate data, and does not reflect a change in practice for screening providers.

ID2 is a small number KPI, therefore the data should be interpreted with caution.

Quarter 3 performance

Reporting period Numerator Denominator Performance %
Quarter 3 2023 to 2024 109 159 68.6%
Region Performance %
East of England 81.2%
London 71.1%
Midlands 76.7%
North East and Yorkshire 69.6%
North West 50.0%
South East 66.7%
South West 50.0%
England 68.6%

2.3 KPI ID3: coverage: hepatitis B

National performance of ID3 (see standard IDPS-S02) in quarter 3 2023 to 2024 was 99.8%.

Quarter 3 performance

Reporting period Numerator Denominator Performance %
Quarter 3 2023 to 2024 150,987 151,253 99.8%
Region Performance %
East of England 99.8%
London 99.9%
Midlands 99.8%
North East and Yorkshire 99.8%
North West 99.8%
South East 99.8%
South West 99.7%
England 99.8%

2.4 KPI ID4: coverage: syphilis

National performance of ID4 (see standard IDPS-S03) in quarter 3 2023 to 2024 was 99.8%.

Quarter 3 performance

Reporting period Numerator Denominator Performance %
Quarter 3 2023 to 2024 150,985 151,256 99.8%
Region Performance %
East of England 99.8%
London 99.9%
Midlands 99.8%
North East and Yorkshire 99.8%
North West 99.8%
South East 99.8%
South West 99.7%
England 99.8%

3. Sickle cell and thalassaemia screening

3.1 KPI ST1: coverage: antenatal screening

National performance of ST1 (see standard SCT-S01) in quarter 3 2023 to 2024 was 99.8%.

Quarter 3 performance

Reporting period Numerator Denominator Performance %
Quarter 3 2023 to 2024 150,862 151,161 99.8%
Region Performance %
East of England 99.8%
London 99.9%
Midlands 99.8%
North East and Yorkshire 99.8%
North West 99.8%
South East 99.8%
South West 99.6%
England 99.8%

3.2 KPI ST2: test: timeliness of antenatal screening

National performance of ST2 (see standard SCT-S02) in quarter 3 2023 to 2024 was 61.5%.

Quarter 3 performance

Reporting period Numerator Denominator Performance %
Quarter 3 2023 to 2024 93,887 152,543 61.5%
Region Performance %
East of England 64.4%
London 57.9%
Midlands 55.8%
North East and Yorkshire 71.0%
North West 58.0%
South East 62.5%
South West 65.3%
England 61.5%

3.3 KPI ST3: test: completion of family origin questionnaire (FOQ)

National performance of ST3 (see standard SCT-S03) in quarter 3 2023 to 2024 was 97.9%.

Quarter 3 performance

Reporting period Numerator Denominator Performance %
Quarter 3 2023 to 2024 149,091 152,319 97.9%
Region Performance %
East of England 97.8%
London 99.7%
Midlands 96.6%
North East and Yorkshire 98.1%
North West 97.5%
South East 97.2%
South West 98.4%
England 97.9%

3.4 KPI ST4a: referral: timely offer of prenatal diagnosis (PND) to women at risk of having an infant with sickle cell disease or thalassaemia

National performance of ST4a (see standard SCT-S05) in quarter 3 2023 to 2024 was 44.9%. Thresholds have not yet been set for this KPI.

ST4a is a small number KPI, therefore the data should be interpreted with caution.

Quarter 3 performance

Reporting period Numerator Denominator Performance %
Quarter 3 2023 to 2024 207 461 44.9%
Region Performance %
East of England 50.0%
London 48.9%
Midlands 35.3%
North East and Yorkshire 61.4%
North West 37.0%
South East 33.3%
South West 40.0%
England 44.9%

3.5 KPI ST4b: referral: timely offer of prenatal diagnosis (PND) to couples at risk of having an infant with sickle cell disease or thalassaemia

National performance of ST4b (see standard STC-S05) in quarter 3 2023 to 2024 was 65.6%. Thresholds have not yet been set for this KPI.

ST4b is a small number KPI, therefore the data should be interpreted with caution.

Quarter 3 performance

Reporting period Numerator Denominator Performance %
Quarter 3 2023 to 2024 206 314 65.6%
Region Performance %
East of England 79.2%
London 72.0%
Midlands 66.2%
North East and Yorkshire 62.3%
North West 52.8%
South East 57.1%
South West 60.0%
England 65.6%

4. Newborn blood spot screening

4.1 KPI NB1: coverage of CCG responsibility at birth

National performance of NB1 (see standard NBS-S01a) in quarter 3 2023 to 2024 was 97.0%.

Quarter 3 performance

Reporting period Numerator Denominator Performance %
Quarter 3 2023 to 2024 134,371 138,517 97.0%
Region Performance %
East of England 99.7%
London 95.9%
Midlands 96.6%
North East and Yorkshire 97.3%
North West 96.3%
South East 97.6%
South West 96.4%
England 97.0%

4.2 KPI NB2: test: quality of the blood spot sample

National performance of NB2 (see standard NBS-S06) in quarter 3 2023 to 2024 was 2.6%.

Quarter 3 performance

Reporting period Numerator Denominator Performance %
Quarter 3 2023 to 2024 3,536 136,979 2.6%
Region Performance %
East of England 2.3%
London 2.2%
Midlands 2.5%
North East and Yorkshire 2.9%
North West 2.7%
South East 3.1%
South West 2.4%
England 2.6%

4.3 KPI NB4: coverage of movers in

National performance of NB4 (see standard NBS-S01b) in quarter 3 2023 to 2024 was 77.6%.

Quarter 3 performance

Reporting period Numerator Denominator Performance %
Quarter 3 2023 to 2024 9,821 12,657 77.6%
Region Performance %
East of England 86.4%
London 68.0%
Midlands 71.5%
North East and Yorkshire 85.9%
North West 83.0%
South East 81.9%
South West 77.5%
England 77.6%

5. Newborn hearing screening

5.1 KPI NH1: coverage

National performance of NH1 (see standard NHSP-S01) in quarter 3 2023 to 2024 was 98.9%.

Quarter 3 performance

Reporting period Numerator Denominator Performance %
Quarter 3 2023 to 2024 146,555 148,111 98.9%
Region Performance %
East of England 99.3%
London 98.5%
Midlands 99.2%
North East and Yorkshire 98.9%
North West 98.5%
South East 99.2%
South West 99.0%
England 98.9%

5.2 KPI NH2: diagnosis/intervention – time from screening outcome to attendance at an audiological assessment appointment

National performance of NH2 (see standard NHSP-S05) in quarter 3 2023 to 2024 was 90.6%.

Quarter 3 performance

Reporting period Numerator Denominator Performance %
Quarter 3 2023 to 2024 2,336 2,578 90.6%
Region Performance %
East of England 86.7%
London 93.8%
Midlands 91.0%
North East and Yorkshire 89.9%
North West 85.7%
South East 95.5%
South West 92.9%
England 90.6%

6. Newborn and infant physical examination screening

6.1 KPI NP1: coverage

National performance of NP1 (see standard NIPE-S01) in quarter 3 2023 to 2024 was 96.3%.

Quarter 3 performance

Reporting period Numerator Denominator Performance %
Quarter 3 2023 to 2024 138,421 143,740 96.3%
Region Performance %
East of England 97.0%
London 96.1%
Midlands 96.2%
North East and Yorkshire 96.3%
North West 95.8%
South East 96.1%
South West 97.4%
England 96.3%

6.2 KPI NP3: diagnosis/intervention – timeliness of ultrasound scan of the hips for developmental dysplasia

NP3 (see standard NIPE-S03) was introduced in 2021 to 2022. New KPIs are not published in the first year of data collection. This time is used to improve the data quality and completeness, by revising the definition, adding clarity and / or setting thresholds as required.

In quarter 3 2023 to 2024, national performance of NP3 was 74.1%.

Quarter 3 performance

Reporting period Numerator Denominator Performance %
Quarter 3 2023 to 2024 10,177 13,726 74.1%
Region Performance %
East of England 79.1%
London 72.7%
Midlands 76.3%
North East and Yorkshire 68.4%
North West 70.8%
South East 72.3%
South West 81.9%
England 74.1%
Back to top